BiotechLabore

BiotechLabore is a biotechnology research organization that develops and applies biotechnologies to address challenges in health, agriculture, and industrial biotechnology. The organization combines molecular biology, synthetic biology, bioprocess engineering, and computational biology to create scalable solutions. Headquartered in Europe, it pursues a collaborative model that includes partnerships with universities, startups, and industry partners.

History: BiotechLabore was founded in 2014 by researchers and industry collaborators seeking to accelerate translation of laboratory discoveries into practical applications. It expanded its facilities and staff through later partnerships and public funding programs. The organization operates multiple laboratories and a pilot-scale production area to support both basic research and applied development.

Operations: Core activities include research and development, contract research services, and technology transfer. The organization runs laboratories specialized in molecular biology, cell culture, analytical chemistry, and process development, with capabilities for high-throughput screening and pilot bioprocessing. It licenses technologies or forms joint ventures with external partners and participates in sponsored research projects.

Research focus: Genetic engineering and genome editing, diagnostics and biosensors, synthetic biology and metabolic engineering, and scalable bioprocess development for biologics and enzymes. Data science and computational biology support experimental design and quality control.

Impact and governance: BiotechLabore adheres to biosafety and ethical guidelines, supported by an internal ethics and compliance committee. Governance typically includes a board of directors and a scientific advisory board. Funding sources include client contracts, public grants, and private investments. The organization publishes results in peer-reviewed journals and contributes to open-source software and standards through collaborations.

Notable projects: a rapid diagnostic platform, a scalable enzyme production pipeline, and a modular synthetic biology toolkit.